CHINA SXT PHARMACEUTICALS IN (SXTC)
VGG2161P1403 - Common Stock
CHINA SXT PHARMACEUTICALS IN
NASDAQ:SXTC (11/4/2024, 8:00:00 PM)
After market: 0.488 +0.01 (+1.9%)0.4789
-0.05 (-9.64%)
Company Profile
China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 78 full-time employees. The company went IPO on 2019-01-04. The firm develops, manufactures and sells three types of TCMP products: advanced TCMP, fine TCMP and regular TCMP, and TCM Homologous Supplements (TCMHS) products. The firm sells its TCMP products under three brand names such as Suxuangtang, Hui Chun Tang and Tong Ren Tang. Most of its products are sold on a prescription basis across China.
Company Info
CHINA SXT PHARMACEUTICALS IN
178 Taidong Road North
Taizhou JIANGSU 225300
P: 8652386298290
CEO: Feng Zhou
Employees: 75
Website: http://www.sxtchina.com/
SXTC News
a month ago - China SXT Pharmaceuticals, Inc.China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price Deficiencya month ago - China SXT Pharmaceuticals, Inc.China SXT Pharmaceuticals, Inc. Received Nasdaq Notification Letter Regarding Bid Price DeficiencyJiangsu, China, , Oct. 07, 2024 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (“SXTC” or the “Company”), (NASDAQ: SXTC) announced today that on...
3 months ago - InvestorPlaceWhat Is Going on With Regencell Bioscience (RGC) Stock Today?Although Regencell Bioscience likely skyrocketed on its novel traditional therapeutics approach, RGC stock is highly speculative.
SXTC Twits
Here you can normally see the latest stock twits on SXTC, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
